Revista de Ciencias de la Salud

  • ISSN: 1108-7366
  • Índice h de la revista: 51
  • Puntuación de cita de revista: 10.69
  • Factor de impacto de la revista: 9.13
Indexado en
  • Genamics JournalSeek
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • CiteFactor
  • CINAHL Completa
  • cimago
  • Biblioteca de revistas electrónicas
  • Directorio de indexación de revistas de investigación (DRJI)
  • EMCare
  • OCLC-WorldCat
  • Comisión de Becas Universitarias
  • Fundación de Ginebra para la Educación e Investigación Médica
  • pub europeo
  • Google Académico
  • SHERPA ROMEO
  • Laboratorios secretos de motores de búsqueda
Comparte esta página

Abstracto

N-linked Glycosylation and its Potential Application in Drug Development

Shilei Wang, Quanyong He, Jinlei Ye, Zhichao Kang, Qiping Zheng, Shuo Liu, Jun He and Lichun Sun

Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).